Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you downgrade to Basic or cancel with-in 10 days of first subscribing, we will refund your payment upon request. Immediately after downgrading or cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Relay Medical Corp. (C:RELA)

Business Focus: Medical Diagnostic & Testing Equipment

Log in or join to add this stock to your watch list.
May 17, 2019 01:00 pm ET
Relay Medical Announces Closing of Private Placement for Proceeds of Over $1.5M
Toronto, Ontario--(Newsfile Corp. - May 17, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the closing of a private placement financing (the "Offering") for gross proceeds of $1,532,500 through the issuance of 7,662,500 Units (each, a "Unit") at a price of $0.20 per unit.
May 16, 2019 12:05 pm ET
Relay Medical Commences Second Pharmatrac User Study and Reports on Development Activities
Toronto, Ontario--(Newsfile Corp. - May 16, 2019) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, reports on Pharmatrac development activities and the commencement of a user study on the Pharmatrac in-home countertop medication appliance.
May 14, 2019 12:05 pm ET
Relay Medical Reports on Technical Advancement of HemoPalm System
Toronto, Ontario--(Newsfile Corp. - May 14, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on technical advances of the Company's enhanced HemoPalm point-of-care (POC) testing platform.
Apr 07, 2019 11:00 pm ET
AgraFlora Organics and Relay Medical Reports on Initial Technology Asset Transfer for Glow LifeTech Ltd.
VANCOUVER and TORONTO, April 8, 2019 /CNW/ - AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, and Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, jointly referred to as the "Partners", are pleased to announce the execution of an asset sale agreement ("Agreement") to transfer a suite of technology assets including the cannabis Smart Consumption System from Relay Medical Corp. to Glow LifeTech Ltd. ("Gl
Apr 03, 2019 11:00 pm ET
AgraFlora Organics and Relay Medical Announce Letter of Intent between Glow LifeTech Ltd. and Ateba Resources Inc. for Go-Public Transaction
VANCOUVER and TORONTO, April 4, 2019 /CNW/ - AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, and Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, jointly referred to as the "Partners", are pleased to announce the execution of a binding letter of intent ("LOI") to bring Glow LifeTech Ltd. ("Glow"), the cannabis technology joint venture, public by way of reverse takeover. In December 2018 the Partners j
Mar 31, 2019 10:55 pm ET
Relay Medical Strengthens Board of Directors with Established Software, Financial and Pharma Executives
Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2)  ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce Messrs. Sid Thomas, Medhanie Tekeste and Greg Van Staveren as new appointments to the Company's Board of Directors. The appointments are effective immediately.
Feb 12, 2019 10:00 pm ET
Paul Glavina Joins Relay Medical and HemoPalm Team as Vice President, In Vitro Diagnostics
Toronto, Ontario--(Newsfile Corp. - February 13, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company”), an engine of MedTech innovation, is pleased to announce the appointment of Paul Glavina as Vice President, In Vitro Diagnostics, of Relay Medical Corp.
Feb 11, 2019 11:10 am ET
Relay Medical Announces Pharmatrac Digital Label Design and Development Activities
Toronto, Ontario--(Newsfile Corp. - February 11, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on development activities and hardware design on the Pharmatrac medication management technology. Following the completion of the first Relay led Pharmatrac user study, the Company is pleased to present the Pharmatrac's digital label hardware design.
Feb 06, 2019 09:55 pm ET
Relay Medical Reports Progress on Enhanced HemoPalm System Design and Provides Update on Product Development and Market Advancement Activities
Toronto, Ontario--(Newsfile Corp. - February 7, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the advancement of the Company's HemoPalm technology and Relay's enhanced HemoPalm system design as well as market advancement activities as the Company continues to build toward productization of this unique point-of-care (POC) testing platform.
Feb 03, 2019 09:55 pm ET
Relay Medical Provides 2018 Overview
Toronto, Ontario--(Newsfile Corp. - February 4, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an overview of operations and developments for 2018.
Dec 19, 2018 09:00 pm ET
Relay Medical Corp. and AgraFlora Organics International Inc. Form Glow Life Technologies Ltd. for the Development of Medical Technologies in the Cannabis Sector
VANCOUVER and TORONTO, Dec. 20, 2018 /CNW/ - Relay Medical Corp. ("Relay") (CSE: RELA, OTCQB: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, and AgraFlora Organics International Inc. ("AgraFlora Organics") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, and jointly referred to as the "Partners", are pleased to announce the formation of the private company Glow Life Technologies Ltd. ("Glow") to pursue medical related technology opportunities in the global cannabis sector.
Dec 13, 2018 11:05 am ET
Relay Medical Appoints Executives; John Soloninka Appointed Senior Vice-President, Acquisitions and Exits; Yoav Raiter as Director, Product Development
Toronto, Ontario--(Newsfile Corp. - December 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of John Soloninka as Senior Vice-President of Acquisitions and Exits and Yoav Raiter as Director of Product Development. The appointments have been made in support of the Company's multi-project integrated accelerator model.
Nov 20, 2018 11:29 am ET
Relay Medical Commences User Studies on Pharmatrac Medication Management Technology
Toronto, Ontario--(Newsfile Corp. - November 20, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the commencement of user studies on the Company's wholly-owned Pharmatrac medication management technology. In conjunction, Relay Medical has engaged the research and systems design firm Human Factors North Inc. (HFN) to design and manage the Toronto, Ontario based user studies.
Nov 14, 2018 10:05 pm ET
Relay Medical Introduces the Pharmatrac Technology and Reports on Development
Toronto, Ontario--(Newsfile Corp. - November 15, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to introduce the Company's Pharmatrac Technology and report on related development activities. The Pharmatrac is a UX-centric (user experience) system designed to improve management and identification of medications.
Nov 12, 2018 10:05 pm ET
Relay Medical Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - November 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on two propriety software developments and the expansion of the Company's headquarters and development facilities. The software developments include a cloud-based regulatory management system and a modular software development toolkit for rapid prototyping and proprietary development.
Sep 24, 2018 05:58 pm ET
Relay Medical To Commence Trading in United States as RYMDF
Toronto, Ontario--(Newsfile Corp. - September 24, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an update on the Company's trading status in the United States.
Aug 23, 2018 12:05 pm ET
Relay Medical Signs Term Sheet for New Product Acquisition
Toronto, Ontario--(Newsfile Corp. - August 23, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the signing of a term sheet to acquire a gynecological clinical invention. The invention addresses postoperative gynecological complications and is intended to address a clear clinical need and a very large market. This acquisition represents an opportunity for product development in-line with the Company's mission to expand its portfolio of assets.
Aug 08, 2018 12:08 pm ET
Letter from Lahav Gil, Relay Medical CEO
Toronto, Ontario--(Newsfile Corp. - August 8, 2018) - Relay Medical Corp. (the "Company" or "Relay") (CSE: RELA) (OTC: CHXIF) (FSE: EIY2) (WKN: A2JQR0) is pleased to release the following letter from Lahav Gil, Company CEO.
Aug 03, 2018 12:05 pm ET
Relay Medical Announces Completion of Private Placement Raising Aggregate Gross Proceeds of $2,251,200.44
Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - Relay Medical Corp. ("Relay" or the "Company") (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2), a developer of MedTech innovation, is pleased to announce that the Company has completed the second and final tranche (the "Second Tranche") of the placement offering (the "Offering") for gross proceeds of $640,000.76 through the issuance of 2,782,612 units (each, a "Unit") at a price of $0.23 per Unit. The aggregate gross proceeds raised pursuant to the Offering was $2,251,200.44 through the issuance of 9,787,828 Units.
Aug 02, 2018 11:00 pm ET
Relay Medical Provides HemoPalm Update
Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide an update on recent development activities related to the Company's HemoPalm product.
Jul 27, 2018 12:05 pm ET
Relay Medical Announces Closing of Private Placement for Proceeds of Over $1.6M
Toronto, Ontario--(Newsfile Corp. - July 27, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company has closed a private placement offering (the "Offering") for gross proceeds of $1,611,199.68 through the issuance of 7,005,216 units (each, a "Unit") at a price of $0.23 per Unit.